ESR1 and adenocarcinoma: The cytotoxic activity of both extracts was evaluated on breast non-tumorigenic ER- cell line (MCF-12A), breast estrogen-dependent (ER+) cells (MCF-7), and metastatic estrogen-independent (ER−) adenocarcinoma cells using MTS and LDH assays.